Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1304-1307

  Inskip, H M ^a   Kinlen, L J ^b   Taylor, A M R ^c   Woods, C G ^d   Arlett, C F ^e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Ataxia telangiectasia; Breast cancer; Cancer mortality

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER MORTALITY; CANCER RISK; FEMALE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HETEROZYGOTE; HUMANS; MALE; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032983665     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690209     Document Type: Article

References (14)

1. Athma P, Rappaport R and Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134
2. Bishop DT and Hopper J (1997) AT-tributable risks? Nat Genet 15: 226
3. Borresen AL, Anderson TL, Treti S, Heiberg A and Moller P (1990) Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2: 339-340
4. Breslow NE and Day NE (1987) Statistical Methods in Cancer Research, Vol 2. The Design and Analysis of Cohort Studies. International Agency for Research on Cancer Lyon
5. Bridges B and Arlett C (1992) Risk of breast cancer in ataxia-telangiectasia. N Engl J Med 326: 1357
6. Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 6: S177-S182
7. Fitzgerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ and Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307-310
8. Pippard EC, Hall AJ, Barker DJP and Bridges BA (1988) Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929-2932
9. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
10. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P and Dohner H (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukaemia. Nat Med 3: 1155-1160
11. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F and Stern MH (1998) Inactivations of the ATM gene in T cell prolymphocytic leukaemia. Blood 91: 3920-3926
12. Swift M, Reitnauer PJ, Morrell D and Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289-1294
13. Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Eng J Med 325: 1831-1836
14. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot P, Yaxley JC, Foroni L, Hammarstrom L, Webster ADB and Yuille MAR (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T cell leukaemia. Nat Genet 17: 96-99